IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.98 HKD | -1.96% |
|
-4.38% | -53.24% |
| 06-03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
| 05-30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Bio Therapeutic Drugs | -1.96% | -4.38% | -53.24% | - | - | 683M |  | | |
